COMMUNIQUÉS West-GlobeNewswire

-
L’Association canadienne pour l’équité en santé des femmes et la Fondation Pharmaprix pour la santé des femmes(MD) renforcent leur partenariat par une promesse de don d’un million de dollars pour la recherche et les soins en santé
12/08/2025 -
Women’s Health Collective Canada and Shoppers Foundation for Women’s Health™ Deepen Partnership with $1 Million Commitment to Health Research and Care
12/08/2025 -
Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy
12/08/2025 -
WeightWatchers Launches Inaugural Awards, Honoring Top Picks in Health and Wellness Products
12/08/2025 -
San Diego Charity Golf Tournament at Maderas Golf Club to Support Veterans, First Responders, and NUCCA Awareness
12/08/2025 -
SoldierStrong Joins Face the Fight® Coalition to Combat Veteran Suicide
12/08/2025 -
AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
12/08/2025 -
Health system adoption of AI outpaces internal governance and strategy
12/08/2025 -
Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.
12/08/2025 -
Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results
12/08/2025 -
argenx and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis
12/08/2025 -
TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
12/08/2025 -
NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues
12/08/2025 -
Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights
12/08/2025 -
Altimmune Announces Second Quarter 2025 Financial Results and Business Update
12/08/2025 -
Endure Biotherapeutics Receives SBIR Phase I Grant to Advance Engineered Native Bacteria Therapy for Familial Adenomatous Polyposis
12/08/2025 -
Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights
12/08/2025 -
Ocular Therapeutix™ Receives FDA Agreement Under Special Protocol Assessment (SPA) for Registrational Trial of AXPAXLI™ in NPDR
12/08/2025 -
SRx Health Solutions Initiates Restructuring Proceedings under CCAA for its Canadian Subsidiary
12/08/2025
Pages